Inicio > Medicina > Enfermería y servicios auxiliares > Farmacia/prescripción/dispensación > Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives
Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives

Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives

Tsukasa Mizuhara

68,21 €
IVA incluido
Disponible
Editorial:
Springer Nature B.V.
Año de edición:
2016
Materia
Farmacia/prescripción/dispensación
ISBN:
9784431561651
68,21 €
IVA incluido
Disponible

Selecciona una librería:

  • Librería Samer Atenea
  • Librería Aciertas (Toledo)
  • Kálamo Books
  • Librería Perelló (Valencia)
  • Librería Elías (Asturias)
  • Donde los libros
  • Librería Kolima (Madrid)
  • Librería Proteo (Málaga)

The author successfully developed novel anti-HIV PD 404182 derivatives that exhibited submicromolar inhibitory activity against both HIV-1 and HIV-2. His thesis is in three parts. The first part expounds efficient methods for the synthesis of tricyclic heterocycles related to PD 404182 based on the sp2-carbon−heteroatom bond formations. Starting from arene or haloarene, C-O, C-N, or C-S bonds were formed by simply changing the reactants. These synthetic methods provide powerful approaches for the divergent preparation of pyrimido-benzoxazine, -quinazoline, or -benzothiazine derivatives. The second part explains SAR studies of PD 404182 for the development of anti-HIV agents. Through optimization studies of the central 1,3-thiazin-2-imine core, the benzene and cyclic amidine ring parts, 3-fold more potent inhibitors were obtained compared with the lead compound. The author also reveals by a time-of-drug-addition experiment that PD 404182 derivatives impaired HIV replication at the binding or fusion stage. The third part of the thesis elucidates the development of photoaffinity probes for the target identification of PD 404182. By the photolabeling experiment of HIV-1-infected H9 cells using these probes, the author detected proteins specifically bound to PD 404182. These new anti-HIV agents may be promising agents for anti-HIV therapy because their mechanisms of action differ from those of the currently approved anti-HIV agents.

Artículos relacionados

  • HPLC Basics
    Rajashekar Vadlakonda / Sarangi Ramesh / Upender Rao Eslawath
    This book describes the powerful analytical technique, i.e., HPLC, used to separate, identify, and quantify components in a mixture. This book is helpful for various fields, including pharmaceuticals, biochemistry, environmental analysis, food and beverage testing, and forensics. This book discusses the types of HPLC apparatus, their use, components, standard operating procedur...
    Disponible

    14,52 €

  • Leading Without Heart
    DaOnda Combs-Payne
    I chose pharmacy for its unique position in the healthcare arena for its ability to transcend and break through barriers to patient care. I watch as the profession continues to spiral downward with the claims of a pharmacist shortage.A program called the Pharmacy Workplace and Well-Being Report allows pharmacy employees to submit both positive and negative experiences with hope...
  • The Beauty of Witchcraft, Vol. II
    Lord Ph.D. Beauchamp
    The perception and treatment of witches varied throughout different regions and time periods, most of those accused and persecuted as witches were women, and their practices often revolved around folk medicine and healing. During the Middle Ages, the belief in witchcraft was widespread across Europe. The Church played a significant role in shaping the perception of witches, vie...
    Disponible

    9,31 €

  • Phresh Pharmacy
    Meyada Widaatalla
    Retail pharmacists today are facing pressure to perform more clinical duties in an environment that is business-driven. The only changes that seem to be happening are the addition of clinical services that pharmacists can perform within their scope of practice. These services, including immunizations, medication reviews and prescribing for minor ailments, can greatly benefit pa...
  • Converging Pharmacy Science and Engineering in Computational Drug Discovery
    The world of pharmaceutical research is moving at lightning speed, and the age-old approach to drug discovery faces many challenges. It’s a fascinating time to be on the cutting edge of medical innovation, but it’s certainly not without its obstacles. The process of developing new drugs is often time-consuming, expensive, and fraught with uncertainty. Researchers are constantly...
  • Converging Pharmacy Science and Engineering in Computational Drug Discovery
    The world of pharmaceutical research is moving at lightning speed, and the age-old approach to drug discovery faces many challenges. It’s a fascinating time to be on the cutting edge of medical innovation, but it’s certainly not without its obstacles. The process of developing new drugs is often time-consuming, expensive, and fraught with uncertainty. Researchers are constantly...
    Disponible

    430,58 €

Otros libros del autor

  • Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives
    Tsukasa Mizuhara
    The author successfully developed novel anti-HIV PD 404182 derivatives that exhibited submicromolar inhibitory activity against both HIV-1 and HIV-2. His thesis is in three parts. The first part expounds efficient methods for the synthesis of tricyclic heterocycles related to PD 404182 based on the sp2-carbon−heteroatom bond formations. Starting from arene or haloarene, C-O, C-...